The Irish government’s move to ensure patients have access to medical cannabis has been tentatively welcomed by campaigners.
Following repeated calls from campaigners, Ireland’s Government announced that an arrangement to assist patients in accessing cannabis medicines would be made permanent.
Minister for Health, Stephen Donnelly, confirmed on Monday 14 December, they would no longer need to travel to the Netherlands to collect their medication, with the delivery service remaining in place one travel restrictions were lifted.
Prior to the coronavirus pandemic, patients or their family members were forced to travel to the Netherlands to collect their prescriptions and take them home to Ireland.
But due to the lockdown restrictions, the Health Service Executive (HSE) arranged for the importation and delivery of cannabis medicines for around 50 patients who are prescribed it under individual licences to ensure they would have access to their medication.
One of those was 11-year-old Ava Barry, who has a severe form of epilepsy known as Dravet syndrome and has been taking medical cannabis to control her seizures for the last four years.
Her mum, high profile campaigner, Vera Twomey – who was crucial in leading the fight for access to medical cannabis in Ireland – has been pleading with the ministers for months to make the arrangement permanent once restrictions were lifted.
Last month she wrote an open letter to Minister Donnelly and Prime Minister Micheál Martin, warning that travelling overseas every 12 weeks would put her at risk of contracting the virus, which could be ‘fatal’ for her daughter, who has a weakened immune system due to her condition.
Speaking earlier this week, Minister Donnelly said: “Many patients and their families have shared stories with both me and officials in my department about how this initiative has made a huge improvement to their lives. They spoke about the stress of having to travel regularly and the associated health risks with that, as well as their concerns that they would run out of their medication
“I am so pleased that these problems will now be a thing of the past for them. There will no longer be a need for them to travel abroad in order to collect their prescribed cannabis products. Instead, they can focus on their health and wellbeing. The welfare of patients and their families comes first and I am happy to reassure them that they will no longer have to personally source their prescriptions.”
Vera has thanked everyone who helped her campaign, describing the announcement as ‘positive’ but added that it is now vital patients see the details of how they plan to proceed.
Officials in the Department of Health are said to be finalising the arrangements of how the collection and delivery service will work on a permanent basis moving forwards.
The announcement has been widely welcomed in Ireland and the UK, but others say this isn’t enough.
For approximately 50. Out of 5 million. These 50 are still expected to come up with funds to cover the cost of these extortionate prescriptions while other countries have legal, affordable dispensaries for medical cannabis as well as the right to grow at home.
— Cork Cannabis Activist Network (Ireland) (@Cork_CAN) December 14, 2020
The Cork Cannabis Activists Network pointed out that thousands of patients are still expected to cover the costs of their prescriptions, leaving millions of patients forced to turn to illicit sources as access to medical cannabis remains a critical issue in Ireland.
Responding to the news on Twitter the group commented: “These 50 [patients] are still expected to come up with funds to cover the cost of these extortionate prescriptions, while other countries have legal, affordable dispensaries for medical cannabis as well as the right to grow at home.”
NFL to explore effects of CBD in players with chronic pain
America’s National Football League (NFL) is looking into how cannabis and CBD can help in managing player’s chronic pain.
The league and player’s association (NFLPA) made a formal request for information to researchers on “pain management alternatives to opioids” earlier this month.
In an official statement, the NFL-NFLPA Pain Management Committee (PMC) said it is working to “improve player health through evidence-based treatment of acute and chronic pain” and to “facilitate research to better understand and improve potential alternative treatments.”
The NFL is seeking out qualified researchers who could lead studies into pain management and athletic performance in its players.
Areas of investigation include the potential therapeutic role of medications and “non-pharmacological interventions” that are considered to be alternatives to opioids in routine pain management of NFL players, including, but not limited to, cannabinoids such as CBD.
The committee also wants to explore the cannabis or cannabinoids on athletic performance in NFL players.
The PMC was formed in 2019 as part of the NFL-NFLPA Collective Bargaining Agreement with the goal of benefitting the health and safety of NFL players through education and research.
Last year it conducted two informational forums on CBD to learn about the current state of CBD science and manufacturing in the US, as part of its aim to find alternatives to opioids in the pain management of players.
Respondents to the request are expected to have experience conducting controlled, experimental studies in the relevant areas and should be affiliated with institutions or companies that meet state, federal, and IRB requirements.
However the NFL is not committing to funding any specific studies at this stage, and instead wants to seek out qualified scientists who can assist with future research projects.
CBD is not currently listed on the World Anti-Doping Agency’s Prohibited List and, as a result, is permitted for use in sport.
However, all other cannabinoids such as cannabis, marijuana and THC are prohibited in competition due to the receptors activated in the brain which cause a ‘high’.
A 2018 review assessed the impact CBD has on relieving chronic pain. The review examined a number of studies, concluding that CBD was effective in overall pain management and didn’t cause any other negative side effects.
In addition, it has been suggested that CBD can speed recovery and fight fatigue – welcome news for athletes suffering from long-term or recurring injuries.
How can CBD help arthritis?
In the UK, more than 10 million people have arthritis or other, similar conditions that affect the joints – and many are turning to CBD products to ease their pain and discomfort.
With an ever-expanding range of drinks, gummies and edibles on thee market CBD could be seen as something aimed at the younger generation.
However, there is a growing body of research that suggests CBD can also be of great use for the older members of the population – and one condition in particular.
Arthritis is a common condition that causes pain and inflammation in a joint, and while it can affect people of all ages, it is more likely to begin when people are in their 40s and 50s, worsening with age.
A Canadian study from 2020 found that up to one in five patients who consulted an orthopedic surgeon for chronic musculoskeletal pain were using a cannabis product to treat them, with the express aim of reducing pain.
The researchers also found that interest in the compound was high, with two thirds of non-users curious to try a cannabis product to treat their muscle and joint pain.
Furthermore, those patients already using CBD had generally positive experiences using the products. Nine out of 10 said it was effective in managing their pain, and four in 10 said it decreased their reliance on other pain medications. Nearly 6 in 10 said cannabis products were more effective than other drugs.
Such findings corroborate what we already know about CBD; thanks to its anti-inflammatory and analgesic properties, early research into its use as a treatment for acute and chronic pain is promising.
A 2016 study found that transdermal cannabidiol has potential for reducing pain and inflammation associated with arthritis without any noticeable side effects.
Cannabis-based medicines can help manage the pain of arthritis by rebalancing the body’s natural endocannabinoid pain-processing system and soothing inflamed body tissues.
There are two primary ways of taking a CBD supplement; topically or orally.
In the case of arthritis, a cream or ointment containing CBD would be rubbed into the affected area. Topical products may also include common over-the-counter ingredients such as menthol, capsaicin or camphor, which could make it difficult to determine if any positive effect is due to the CBD or another ingredient.
There are a number of ways to take CBD orally, from gummies, snacks and drinks to tinctures and capsules – although gummies are discouraged in households with children, due to their similarity with sweets.
However, all work in largely the same way, being absorbed through the digestive tract. However, it is worth noting that absorption can be slow and dosing is tricky due to the delayed onset of effect (one to two hours), unknown effects of stomach acids, recent meals and other factors.
Whichever method you choose, it is always a good idea to check with your medical practitioner first, as CBD, although it is natural, may interact with other treatments, such as prescription medications.
However, for those looking for an alternative to prescribed drugs, with fewer side effects, CBD could well prove to be the answer.
9 out of 10 readers have self-medicated with cannabis
Nine out of 10 Cannabis Health readers have consumed cannabis for medical purposes without a prescription – and almost all said they found it to be more effective than conventional medicines.
Over the last few weeks, we’ve been asking for your views on social media to delve deeper into how people are consuming cannabis.
As expected, the proportion of our readers who self-medicate with cannabis was high, but the results also demonstrate the perceived effectiveness of cannabis in comparison with traditional medication, highlighting a need for wider access to safe cannabis based medicines.
Despite the law around medical cannabis changing over two years ago, gaining a prescription can still be challenging, particularly on the NHS.
This has forced a lot of patients to take matters into their own hands.
According to research, as many as 1.4 million Brits are self-medicating with cannabis, equivalent to just over two percent of the country’s population.
Studies from the US have backed this up, with one suggesting that as many as a third of teenagers with a chronic health condition have taken it upon themselves to manage their symptoms with cannabis.
We asked our readers if they were self-medicating to treat a health condition, with the results confirming that almost 94 percent of people said they were.
On top of this, a further five percent said they were not currently, but were open to the idea.
Just over one percent said they weren’t self-medicating due to the stigma attached, however no one responded that the law was a factor in this.
Effectiveness of self-medicating
Anecdotal evidence and some early studies suggest that cannabis can ease symptoms of some chronic pain conditions, such as fibromyalgia, where other, more conventional medicines have failed.
There is also promise in the potential of cannabis to relieve some mental health conditions, with some saying it has provided huge relief for disorders such as PTSD.
Ninety five percent of Cannabis Health readers polled said they found cannabis extremely effective at relieving symptoms.
In addition no one said they had found it ineffective when it comes to treating their condition.
The remaining five percent said they found it to have a similar effect as their conventional treatments.
Route to administration
How patients consume cannabis can have an impact on its effectiveness, as well as how quickly it kicks in.
With such high numbers both self-medicating and reporting positive effects, we wanted to discover the common consumption methods.
Smoking the flower is the traditional method of consuming cannabis and often viewed as the one which can provide the most relief.
However, even though it has been seen to be less harmful than tobacco, smoking can still lead to a number of other health issues and is note recommended by health professionals.
Despite this, it remained the most popular choice among Cannabis Health readers, with just over a third saying this is how they consume cannabis.
The modern alternative to this is vaping, which was the second most common route to administration among Cannabis Health readers.
Around a third of readers said this was their preferred consumption method.
Some professionals argue this is the healthiest way for consumption, with clinics recommending vaping cannabis flower, but more research is needed in this area.
One method which has few negative effects is the use of oils or tinctures.
This is typically how CBD is consumed, with 21 percent of readers saying this was their preferred method.
Self-medicating alongside conventional medicines
The NHS says it is unlikely that many people in the UK will be able to gain access to a medical cannabis prescription.
Despite this, many patients have chosen to self-medicate with cannabis either alongside or often in the place of conventional therapies.
The majority of readers agreed with this, with 55 percent saying they no longer use conventional medicines in favour of cannabis.
A further 22 percent said they would only use their conventional medicines if they did not have access to cannabis and the remainder said that they still consume cannabis alongside conventional medication.
Want to get involved? Cannabis Health will be running a number of polls over on our social media pages, to find out more about your views on CBD and cannabis for medical and wellbeing purposes.
- NFL to explore effects of CBD in players with chronic pain
- How can CBD help arthritis?
- 9 out of 10 readers have self-medicated with cannabis
- Cannabis may lead to “rebound” headaches in migraine patients – study
- Always Pure Organics: “The UK is a front runner in establishing a regulated CBD market”
- Cannabis-based drug may offer “new hope” for brain tumour patients – study
News7 months ago
NHS lines up cannabis medicine manufacturing
News3 months ago
Community extends support to cannabis icon Rick Simpson
Case Studies11 months ago
CBD oil and fibromyalgia – a case study
Feature8 months ago
Medical cannabis could help long-term effects of COVID-19, says David Nutt
Insight5 months ago
I’ve gone from a wheelchair to walking thanks to cannabis
News5 months ago
“I’m not a bad person” – chronically ill woman convicted of growing medical cannabis
News5 months ago
Cancer survivor claims cannabis oil helped her beat brain tumour
Industry5 days ago
Cannabliss to open brick and mortar dispensary